Health ❯Healthcare

Drug Development

Clinical Trials Clinical Research Regulatory Affairs FDA Approval Cancer Treatment Pharmaceutical Research FDA Regulations Generic Drugs Antimalarial Drugs Clinical Studies

FDA Publishes Over 200 Complete Response Letters for 2020–24 Drug Applications

The release aims to demystify the FDA’s review process through transparent feedback redacted for confidentiality.

Stories older than 24h

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Cidara’s CD388 Antiviral Achieves Up to 76% Flu Protection in Phase 2b Trial

Dr. Reddy’s and Alvotech Partner to Develop Global Keytruda Biosimilar

Alzheimer’s Drug Trials Surge 11% in 2025 as NICE Reviews Lecanemab and Donanemab

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

Camizestrant Cuts Breast Cancer Progression Risk by Over Half in Global Trial

Mixed Phase 3 Outcomes Cloud Future of Regeneron and Sanofi’s COPD Candidate Itepekimab

MIT-Harvard Study Identifies New Alzheimer’s Drug Targets in RNA and DNA Pathways

Researchers Uncover Brain Ion Channel's Role in Molecular Memory

Researchers Identify Broad-Spectrum Inhibitors for Malaria Parasite's Key Protein Family

Study Reveals Sex-Based Protein Differences Driven by Non-Genetic Factors

Biontech Reports Q1 Loss as Focus Shifts to mRNA Cancer Therapies

Eli Lilly Reports Record Q1 Revenue but Faces Profit Pressure and Competitive Challenges

Zongertinib Achieves Breakthrough in Treating HER2-Mutant Lung Cancer

UK Grants First Global Approval for GSK’s Blenrep in Two Combination Therapies

FDA Launches Immediate Plan to Replace Animal Testing with Human-Relevant Methods

FDA Launches Roadmap to Phase Out Animal Testing in Drug Development